Biotech / Pharma
Glycomantra, Inc.
Biotech / Pharma
Washington, DC glycobiology biotech developing galectin-3-targeted therapeutics for cancer and NASH; holds an NIH/NIDDK Phase II SBIR grant for a Type 2 diabetes drug.
Founded
Region
Investors
People